294 related articles for article (PubMed ID: 16971318)
1. Abatacept: A review of a new biologic agent for refractory rheumatoid arthritis for dermatologists.
Scheinfeld N
J Dermatolog Treat; 2006; 17(4):229-34. PubMed ID: 16971318
[TBL] [Abstract][Full Text] [Related]
2. [Abatacept in the treatment of active rheumatoid arthritis].
Nielsen H; Hansen A
Ugeskr Laeger; 2009 Jan; 171(4):214-7. PubMed ID: 19174034
[TBL] [Abstract][Full Text] [Related]
3. The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis.
Ruderman EM; Pope RM
Arthritis Res Ther; 2005; 7 Suppl 2(Suppl 2):S21-5. PubMed ID: 15833145
[TBL] [Abstract][Full Text] [Related]
4. T-cell agents in the treatment of rheumatoid arthritis.
Solomon GE
Bull NYU Hosp Jt Dis; 2010; 68(3):162-5. PubMed ID: 20969545
[TBL] [Abstract][Full Text] [Related]
5. Abatacept mechanism of action: concordance with its clinical profile.
Herrero-Beaumont G; Martínez Calatrava MJ; Castañeda S
Reumatol Clin; 2012; 8(2):78-83. PubMed ID: 22104048
[TBL] [Abstract][Full Text] [Related]
6. Abatacept, a novel CD80/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis.
Korhonen R; Moilanen E
Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):276-84. PubMed ID: 19228144
[TBL] [Abstract][Full Text] [Related]
7. Abatacept in biologic-naïve patients and TNF inadequate responders: clinical data in focus.
Sherrer Y
Curr Med Res Opin; 2008 Aug; 24(8):2283-94. PubMed ID: 18590608
[TBL] [Abstract][Full Text] [Related]
8. [CTLA4-Ig (abatacept)].
Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1231-7. PubMed ID: 17642237
[TBL] [Abstract][Full Text] [Related]
9. Rheumatoid arthritis: beyond tumor necrosis factor-alpha antagonists, B cell depletion, and T cell blockade.
Manadan AM; Block JA
Am J Ther; 2008; 15(1):53-8. PubMed ID: 18223354
[TBL] [Abstract][Full Text] [Related]
10. Drug Insight: abatacept for the treatment of rheumatoid arthritis.
Ruderman EM; Pope RM
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):654-60. PubMed ID: 17133250
[TBL] [Abstract][Full Text] [Related]
11. [Fusion protein abatacept. Remission in every 5th TNF-alpha refractory patient].
MMW Fortschr Med; 2008 Jun; 150(26-27):56-7. PubMed ID: 18683309
[No Abstract] [Full Text] [Related]
12. [Pharmacological properties and clinical efficacy of abatacept (Orencia(®)) for the treatment of rheumatoid arthritis].
Yasuoka Y; Goto A; Seriu T
Nihon Yakurigaku Zasshi; 2011 Feb; 137(2):87-94. PubMed ID: 21321458
[No Abstract] [Full Text] [Related]
13. Role of abatacept in the management of rheumatoid arthritis.
Nogid A; Pham DQ
Clin Ther; 2006 Nov; 28(11):1764-78. PubMed ID: 17212998
[TBL] [Abstract][Full Text] [Related]
14. Use of abatacept in rheumatoid arthritis.
von Kempis J; Dudler J; Hasler P; Kyburz D; Tyndall A; Zufferey P; Villiger PM
Swiss Med Wkly; 2012; 142():w13581. PubMed ID: 22581564
[TBL] [Abstract][Full Text] [Related]
15. Abatacept.
Vital EM; Emery P
Drugs Today (Barc); 2006 Feb; 42(2):87-93. PubMed ID: 16541185
[TBL] [Abstract][Full Text] [Related]
16. Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents.
Picchianti Diamanti A; Rosado MM; Scarsella M; Germano V; Giorda E; Cascioli S; Laganà B; D'Amelio R; Carsetti R
Clin Exp Immunol; 2014 Sep; 177(3):630-40. PubMed ID: 24773026
[TBL] [Abstract][Full Text] [Related]
17. Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation.
Konsta M; Rallis E; Karameris A; Stratigos A; Sfikakis PP; Iliopoulos A
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):257-8. PubMed ID: 22280512
[No Abstract] [Full Text] [Related]
18. Costimulation blockade in autoimmunity and transplantation.
Vincenti F
J Allergy Clin Immunol; 2008 Feb; 121(2):299-306; quiz 307-8. PubMed ID: 18269922
[TBL] [Abstract][Full Text] [Related]
19. Abatacept in the treatment of rheumatoid arthritis.
Todd DJ; Costenbader KH; Weinblatt ME
Int J Clin Pract; 2007 Mar; 61(3):494-500. PubMed ID: 17313619
[TBL] [Abstract][Full Text] [Related]
20. Abatacept: a novel treatment for rheumatoid arthritis.
Lundquist LM
Expert Opin Pharmacother; 2007 Oct; 8(14):2371-9. PubMed ID: 17927490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
